Modifies provisions relating to the requirements for collaborative practice arrangements between physicians and advanced practice registered nurses

HB 1636 modifies rules for collaborative practice between physicians and advanced practice registered nurses (APRNs). It allows APRNs to prescribe certain controlled substances (including Schedule III-V drugs and hydrocodone) under written agreements, with a 120-hour supply limit for most prescriptions. The law requires clear patient disclosure about seeing an APRN, specifies physician review of APRN care, and adds flexibility for rural areas and telehealth regarding geographic proximity requirements between physicians and APRNs. This directly affects APRNs, their patients, and collaborating physicians by expanding prescribing authority while maintaining oversight safeguards.